High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction

Publisher： Bentham Science Publishers

E-ISSN： 1875-676x|11|1|60-65

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.11, Iss.1, 2015-02, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economical Aspects of High-Sensitivity C-Reactive Protein as Predictor of Coronary Heart Disease

By  

Heart Drug, Vol. 2, Iss. 2, 2002-06 ,pp. : 61-68

Karger

Access to resources Recommend Favorite

Editorial [Hot Topic: Modifying Coronary Risk Factors: C-Reactive Protein,Haemostatic Factors and Cardiovascular Risk (Executive Editor: Aurelio Leone)]

By  

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. : 1617-1618

Bentham Science Publishers

Access to resources Recommend Favorite

C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. : 1619-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Positive Association of Serum Levels of Pigment Epithelium-derived Factor with High-sensitivity C-reactive Protein in Apparently Healthy Unmedicated Subjects

By Umei H   Yamagishi S-I   Imaizumi T  

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 443-448

Field House Publishing

Access to resources Recommend Favorite

Statins may benefit patients with high levels of C-reactive protein

By  

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite